phosphodiesterase 2A, CGMP-Stimulated (PDE2A) (N-Term) Peptide
-
- Target See all PDE2A products
- PDE2A (phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
- Protein Region
- N-Term
- Origin
- Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- CRSQQYPAAR PAEPRGQQVF LKPDEPPPQP CADSLQDALL SLGAVIDIAG
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Pde2a Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PDE2A (phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
- Synonyms
- PDE2A Peptide, CGS-PDE Peptide, PDE2A1 Peptide, PED2A4 Peptide, cGSPDE Peptide, Pde2 Peptide, Pde2a2 Peptide, phosphodiesterase 2A Peptide, phosphodiesterase 2A, cGMP-stimulated Peptide, PDE2A Peptide, pde2a Peptide, Pde2a Peptide
- Background
-
The activation of Pde2a induces decreased cAMP accumulation, It is involved in nitric oxide mediated signaling in cardiac fibroblasts.
Alias Symbols: Pde2, Pde2a2, Pde2a
Protein Size: 935 - Molecular Weight
- 104 kDa
- Gene ID
- 81743
- NCBI Accession
- NM_001143847, NP_001137319
- UniProt
- Q01062
-